Tech Company Financing Transactions
Exo Therapeutics Funding Round
On 12/17/2020, Exo Therapeutics received $25 million in Series A financing from 6 Dimensions Capital, CRV and New Path Ventures.
Transaction Overview
Company Name
Announced On
12/17/2020
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds from the financing will be used to advance therapeutic candidates derived from the company's ExoSightTM platform towards proof-of-concept and into the clinic.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
700 Main St. 206
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Undisclosed
Website
Email Address
Overview
Exo Therapeutics is a small molecule drug discovery and development company with a pioneering technology to address intractable pharmaceutical targets.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Bruce
VP - Finance
Paul Schneider
Browse more venture capital transactions:
Prev: 12/17/2020: SnapNurse venture capital transaction
Next: 12/17/2020: Neurogene venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs